rs77592501

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000540.3(RYR1):​c.10687-10C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0613 in 1,613,786 control chromosomes in the GnomAD database, including 4,813 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.053 ( 382 hom., cov: 32)
Exomes 𝑓: 0.062 ( 4431 hom. )

Consequence

RYR1
NM_000540.3 intron

Scores

2
Splicing: ADA: 0.00006909
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 0.227

Publications

10 publications found
Variant links:
Genes affected
RYR1 (HGNC:10483): (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
RYR1 Gene-Disease associations (from GenCC):
  • malignant hyperthermia, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Ambry Genetics, ClinGen
  • RYR1-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia
  • congenital multicore myopathy with external ophthalmoplegia
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • central core myopathy
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • King-Denborough syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant hyperthermia of anesthesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • benign Samaritan congenital myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital myopathy with myasthenic-like onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 19-38527637-C-T is Benign according to our data. Variant chr19-38527637-C-T is described in ClinVar as Benign. ClinVar VariationId is 93241.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.216 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000540.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RYR1
NM_000540.3
MANE Select
c.10687-10C>T
intron
N/ANP_000531.2P21817-1
RYR1
NM_001042723.2
c.10672-10C>T
intron
N/ANP_001036188.1P21817-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RYR1
ENST00000359596.8
TSL:5 MANE Select
c.10687-10C>T
intron
N/AENSP00000352608.2P21817-1
RYR1
ENST00000355481.8
TSL:1
c.10672-10C>T
intron
N/AENSP00000347667.3P21817-2
RYR1
ENST00000594335.6
TSL:1
n.*1415-10C>T
intron
N/AENSP00000470927.2M0R014

Frequencies

GnomAD3 genomes
AF:
0.0528
AC:
8038
AN:
152182
Hom.:
382
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0245
Gnomad AMI
AF:
0.0582
Gnomad AMR
AF:
0.0599
Gnomad ASJ
AF:
0.0608
Gnomad EAS
AF:
0.175
Gnomad SAS
AF:
0.227
Gnomad FIN
AF:
0.0267
Gnomad MID
AF:
0.0791
Gnomad NFE
AF:
0.0502
Gnomad OTH
AF:
0.0569
GnomAD2 exomes
AF:
0.0791
AC:
19766
AN:
250028
AF XY:
0.0854
show subpopulations
Gnomad AFR exome
AF:
0.0237
Gnomad AMR exome
AF:
0.0632
Gnomad ASJ exome
AF:
0.0668
Gnomad EAS exome
AF:
0.162
Gnomad FIN exome
AF:
0.0298
Gnomad NFE exome
AF:
0.0516
Gnomad OTH exome
AF:
0.0735
GnomAD4 exome
AF:
0.0622
AC:
90853
AN:
1461486
Hom.:
4431
Cov.:
33
AF XY:
0.0667
AC XY:
48494
AN XY:
727046
show subpopulations
African (AFR)
AF:
0.0252
AC:
845
AN:
33476
American (AMR)
AF:
0.0629
AC:
2809
AN:
44662
Ashkenazi Jewish (ASJ)
AF:
0.0650
AC:
1698
AN:
26120
East Asian (EAS)
AF:
0.151
AC:
5991
AN:
39662
South Asian (SAS)
AF:
0.213
AC:
18373
AN:
86154
European-Finnish (FIN)
AF:
0.0317
AC:
1690
AN:
53334
Middle Eastern (MID)
AF:
0.0940
AC:
542
AN:
5766
European-Non Finnish (NFE)
AF:
0.0493
AC:
54842
AN:
1111928
Other (OTH)
AF:
0.0673
AC:
4063
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
4895
9791
14686
19582
24477
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2246
4492
6738
8984
11230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0528
AC:
8040
AN:
152300
Hom.:
382
Cov.:
32
AF XY:
0.0553
AC XY:
4120
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.0244
AC:
1016
AN:
41584
American (AMR)
AF:
0.0596
AC:
912
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0608
AC:
211
AN:
3472
East Asian (EAS)
AF:
0.174
AC:
899
AN:
5170
South Asian (SAS)
AF:
0.227
AC:
1092
AN:
4816
European-Finnish (FIN)
AF:
0.0267
AC:
284
AN:
10620
Middle Eastern (MID)
AF:
0.0782
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
0.0502
AC:
3417
AN:
68022
Other (OTH)
AF:
0.0629
AC:
133
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
379
757
1136
1514
1893
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0463
Hom.:
80
Bravo
AF:
0.0498
Asia WGS
AF:
0.227
AC:
787
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
2
Malignant hyperthermia, susceptibility to, 1 (2)
-
-
2
not provided (2)
-
-
1
Central core myopathy (1)
-
-
1
Congenital multicore myopathy with external ophthalmoplegia (1)
-
-
1
Neuromuscular disease, congenital, with uniform type 1 fiber (1)
-
-
1
RYR1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
8.6
DANN
Benign
0.74
PhyloP100
0.23
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000069
dbscSNV1_RF
Benign
0.0060
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77592501; hg19: chr19-39018277; COSMIC: COSV62092662; COSMIC: COSV62092662; API